CARBIDOPA AND LEVODOPA
- Product NDC
- 68001-171
- 11-digit product format
- 680010171
- Labeler code
- 68001
- Product ID
- 68001-171_9d0cb864-53d9-4151-b557-dd5114903d6b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carbidopa and Levodopa
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- BluePoint Laboratories
- Application
- ANDA202323
- Marketing category
- ANDA
- Marketing start
- 2014-01-22
- Marketing end
- 0000-00-00
- Substance
- CARBIDOPA; LEVODOPA
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Aromatic Amino Acid [EPC],Amino Acids, Aromatic [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| CARBIDOPA | ACTIVE INGREDIENT | MNX7R8C5VO | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 3 | |
| LEVODOPA | ACTIVE INGREDIENT | 46627O600J | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 3 | |
| CARBIDOPA ANHYDROUS | ACTIVE MOIETY | KR87B45RGH | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 3 | |
| LEVODOPA | ACTIVE MOIETY | 46627O600J | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 3 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 3 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 3 | |
| HYPROMELLOSE 2208 (4000 MPA.S) | INACTIVE INGREDIENT | 39J80LT57T | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 3 | |
| HYPROMELLOSE 2910 (5 MPA.S) | INACTIVE INGREDIENT | R75537T0T4 | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 3 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68001-171 | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BLUEPOINT LABORATORIES] | 7 | Legacy NDC | 20250322_58a6e76a-f99f-4f0c-9d83-a55a30edda97.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68001-171-00 | 68001017100 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68001-171-00) | 2014-01-22 | 0000-00-00 | No | No | Current |